Editorial comment to Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second‐line treatment with tyrosine kinase inhibitor following first‐line immune‐oncology combination therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of urology 2024-05, Vol.31 (5), p.534-534
1. Verfasser:	Yuasa, Takeshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - secondary Humans Immune Checkpoint Inhibitors - therapeutic use Kidney Neoplasms - drug therapy Kidney Neoplasms - pathology Metastases Prognosis Protein Kinase Inhibitors - therapeutic use Renal cell carcinoma Treatment Outcome Tyrosine Kinase Inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!